Literature DB >> 11751966

Influence of the isotype of the light chain on the properties of IgG.

Ramon F Montaño1, Sherie L Morrison.   

Abstract

It is widely appreciated that the isotype of the H chain of the Ab molecule influences its functional properties. We have now investigated the contribution of the isotype of the L chain to the structural and functional properties of the Ab molecule. In these studies, the L chain variable region of a murine anti-dansyl Ab was joined to either human kappa or lambda constant region domains and expressed with mouse-human chimeric H chains of the four human IgG isotypes. The resulting Abs were secreted as fully assembled molecules although, as has been previously observed, IgG4 with either kappa or lambda L chains was also secreted as HL half-molecules. However, the isotype of the L chain can influence the kinetics of intracellular assembly with IgG1lambda, IgG2lambda, and IgG4lambda assembling more slowly than their kappa counterparts. The isotype of the L chain also influenced the susceptibility of the interchain disulfide bonds to attack by reducing agents with variable effects, depending on the isotype of the H chains. For IgG2, but not for IgG1, -3, and -4, the isotype of the L chain influenced the rate of clearance in mice, with IgG2lambda having a shorter in vivo half-life than IgG2kappa. Only slight differences were also observed between lambda and kappa molecules in their kinetics of binding to and dissociation from the hapten dansyl. These studies demonstrate that the isotype of the L chain has only a slight impact on the structural and functional properties of variable region identical Abs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751966     DOI: 10.4049/jimmunol.168.1.224

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Evolutionary redefinition of immunoglobulin light chain isotypes in tetrapods using molecular markers.

Authors:  Sabyasachi Das; Nikolas Nikolaidis; Jan Klein; Masatoshi Nei
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-21       Impact factor: 11.205

2.  Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effects.

Authors:  Katariina M Hutterer; Robert W Hong; Jonathon Lull; Xiaoyang Zhao; Tian Wang; Rex Pei; M Eleanor Le; Oleg Borisov; Rob Piper; Yaoqing Diana Liu; Krista Petty; Izydor Apostol; Gregory C Flynn
Journal:  MAbs       Date:  2013-04-18       Impact factor: 5.857

3.  T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells.

Authors:  Juan Vera; Barbara Savoldo; Stephane Vigouroux; Ettore Biagi; Martin Pule; Claudia Rossig; Jessie Wu; Helen E Heslop; Cliona M Rooney; Malcolm K Brenner; Gianpietro Dotti
Journal:  Blood       Date:  2006-08-22       Impact factor: 22.113

Review 4.  The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy.

Authors:  Jonathan T Sockolosky; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2015-02-19       Impact factor: 15.470

5.  Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody.

Authors:  Jonathan S Wall; Stephen J Kennel; Mike Paulus; Jens Gregor; Tina Richey; James Avenell; Jeffrey Yap; David Townsend; Deborah T Weiss; Alan Solomon
Journal:  J Nucl Med       Date:  2006-12       Impact factor: 10.057

Review 6.  Monoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addiction.

Authors:  S Michael Owens; William T Atchley; Michael D Hambuchen; Eric C Peterson; W Brooks Gentry
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

7.  Structural and functional characterization of disulfide isoforms of the human IgG2 subclass.

Authors:  Thomas M Dillon; Margaret Speed Ricci; Chris Vezina; Gregory C Flynn; Yaoqing Diana Liu; Douglas S Rehder; Matthew Plant; Brad Henkle; Yu Li; Songpon Deechongkit; Brian Varnum; Jette Wypych; Alain Balland; Pavel V Bondarenko
Journal:  J Biol Chem       Date:  2008-03-12       Impact factor: 5.157

8.  Antigen nature and complexity influence human antibody light chain usage and specificity.

Authors:  Kenneth Smith; Hemangi Shah; Jennifer J Muther; Angie L Duke; Kathleen Haley; Judith A James
Journal:  Vaccine       Date:  2016-04-23       Impact factor: 3.641

9.  Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats.

Authors:  Elizabeth M Laurenzana; Howard P Hendrickson; Dylan Carpenter; Eric C Peterson; W Brooks Gentry; Michael West; Yingni Che; F Ivy Carroll; S Michael Owens
Journal:  Vaccine       Date:  2009-10-01       Impact factor: 3.641

10.  Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity.

Authors:  Yang Shen; Lin Zeng; Aiping Zhu; Tim Blanc; Dipa Patel; Anthony Pennello; Amtul Bari; Stanley Ng; Kris Persaud; Yun Kenneth Kang; Paul Balderes; David Surguladze; Sagit Hindi; Qinwei Zhou; Dale L Ludwig; Marshall Snavely
Journal:  MAbs       Date:  2013-04-08       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.